- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 29.75 | 0.0 | 0.0 | 8.03 | 0.0 | 0.0 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
24Q2 (19) | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 29.75 | 0.0 | 2.01 | 8.03 | 0.0 | 13.63 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
24Q1 (18) | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 29.75 | 0.0 | -0.39 | 8.03 | 0.0 | 18.6 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
23Q4 (17) | 0 | -100.0 | -100.0 | 0 | -100.0 | -100.0 | 0 | -100.0 | -100.0 | 0 | 0 | 0 | 29.75 | 0.0 | 1.74 | 8.03 | 0.0 | 34.05 | 0.00 | 0 | 0 | 0 | -100.0 | -100.0 |
23Q3 (16) | 26.39 | -7.18 | -15.01 | 7.85 | -5.31 | -20.79 | 2.12 | 5.47 | 2.42 | 0 | 0 | 0 | 29.75 | 2.01 | -6.8 | 8.03 | 13.63 | 20.5 | 0.00 | 0 | 0 | 1671 | 0.0 | -17.73 |
23Q2 (15) | 28.43 | -5.14 | -14.26 | 8.29 | -7.37 | -21.27 | 2.01 | -0.99 | -9.46 | 0 | 0 | 0 | 29.16 | -2.36 | -8.17 | 7.07 | 4.38 | 5.6 | 0.00 | 0 | 0 | 1671 | 0.0 | -17.73 |
23Q1 (14) | 29.97 | -9.29 | -6.55 | 8.95 | -7.35 | -16.82 | 2.03 | 2.53 | -12.5 | 0 | 0 | 0 | 29.86 | 2.14 | -10.99 | 6.77 | 13.03 | -6.37 | 0.00 | 0 | 0 | 1671 | 0.0 | -17.73 |
22Q4 (13) | 33.04 | 6.41 | 0.79 | 9.66 | -2.52 | -9.21 | 1.98 | -4.35 | -16.81 | 0 | 0 | 0 | 29.24 | -8.39 | -9.92 | 5.99 | -10.11 | -17.46 | 0.00 | 0 | 0 | 1671 | -17.73 | -17.73 |
22Q3 (12) | 31.05 | -6.36 | -3.33 | 9.91 | -5.89 | -2.84 | 2.07 | -6.76 | -12.66 | 0 | 0 | 0 | 31.92 | 0.51 | 0.5 | 6.67 | -0.42 | -9.65 | 0.00 | 0 | 0 | 2031 | 0.0 | -0.54 |
22Q2 (11) | 33.16 | 3.4 | 6.59 | 10.53 | -2.14 | 9.92 | 2.22 | -4.31 | -0.89 | 0 | 0 | 0 | 31.76 | -5.35 | 3.12 | 6.69 | -7.46 | -7.02 | 0.00 | 0 | 0 | 2031 | 0.0 | -0.54 |
22Q1 (10) | 32.07 | -2.17 | 5.25 | 10.76 | 1.13 | 13.03 | 2.32 | -2.52 | -8.3 | 0 | 0 | 0 | 33.55 | 3.37 | 7.39 | 7.23 | -0.36 | -12.88 | 0.00 | 0 | 0 | 2031 | 0.0 | -0.54 |
21Q4 (9) | 32.78 | 2.05 | -6.93 | 10.64 | 4.31 | 11.65 | 2.38 | 0.42 | -25.62 | 0 | 0 | 0 | 32.46 | 2.21 | 19.96 | 7.26 | -1.6 | -20.09 | 0.00 | 0 | 0 | 2031 | -0.54 | -0.54 |
21Q3 (8) | 32.12 | 3.25 | -0.96 | 10.2 | 6.47 | 8.86 | 2.37 | 5.8 | -21.52 | 0 | 0 | 0 | 31.76 | 3.12 | 9.91 | 7.38 | 2.48 | -20.77 | 0.00 | 0 | 0 | 2042 | 0.0 | -11.64 |
21Q2 (7) | 31.11 | 2.1 | -9.72 | 9.58 | 0.63 | -0.52 | 2.24 | -11.46 | -30.22 | 0 | 0 | 0 | 30.79 | -1.44 | 10.19 | 7.20 | -13.28 | -22.7 | 0.00 | 0 | 0 | 2042 | 0.0 | -11.64 |
21Q1 (6) | 30.47 | -13.49 | -9.75 | 9.52 | -0.1 | -1.65 | 2.53 | -20.94 | -21.18 | 0 | 0 | 0 | 31.24 | 15.47 | 8.97 | 8.30 | -8.61 | -12.67 | 0.00 | 0 | 0 | 2042 | 0.0 | -9.81 |
20Q4 (5) | 35.22 | 8.6 | -4.73 | 9.53 | 1.71 | -9.67 | 3.2 | 5.96 | -5.04 | 0 | 0 | 0 | 27.06 | -6.35 | -5.18 | 9.09 | -2.43 | -0.33 | 0.00 | 0 | 0 | 2042 | -11.64 | -9.81 |
20Q3 (4) | 32.43 | -5.89 | 0.0 | 9.37 | -2.7 | 0.0 | 3.02 | -5.92 | 0.0 | 0 | 0 | 0.0 | 28.89 | 3.39 | 0.0 | 9.31 | -0.03 | 0.0 | 0.00 | 0 | 0.0 | 2311 | 0.0 | 0.0 |
20Q2 (3) | 34.46 | 2.07 | 0.0 | 9.63 | -0.52 | 0.0 | 3.21 | 0.0 | 0.0 | 0 | 0 | 0.0 | 27.95 | -2.54 | 0.0 | 9.32 | -2.03 | 0.0 | 0.00 | 0 | 0.0 | 2311 | 2.08 | 0.0 |
20Q1 (2) | 33.76 | -8.68 | 0.0 | 9.68 | -8.25 | 0.0 | 3.21 | -4.75 | 0.0 | 0 | 0 | 0.0 | 28.67 | 0.48 | 0.0 | 9.51 | 4.31 | 0.0 | 0.00 | 0 | 0.0 | 2264 | 0.0 | 0.0 |
19Q4 (1) | 36.97 | 0.0 | 0.0 | 10.55 | 0.0 | 0.0 | 3.37 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 28.54 | 0.0 | 0.0 | 9.12 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 2264 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 (10) | 129.31 | 2.25 | 40.87 | 2.33 | 8.59 | -9.77 | 0 | 0 | 31.61 | 0.08 | 6.64 | -11.75 | 0.00 | 0 | 2031 | 0.0 |
2021 (9) | 126.47 | -6.92 | 39.94 | 4.53 | 9.52 | -24.68 | 0 | 0 | 31.58 | 12.3 | 7.53 | -19.09 | 0.00 | 0 | 2031 | -0.54 |
2020 (8) | 135.87 | -4.63 | 38.21 | -10.45 | 12.64 | -7.74 | 0 | 0 | 28.12 | -6.11 | 9.30 | -3.26 | 0.00 | 0 | 2042 | -11.64 |
2019 (7) | 142.46 | -2.2 | 42.67 | -8.24 | 13.7 | -7.68 | 0 | 0 | 29.95 | -6.18 | 9.62 | -5.61 | 0.00 | 0 | 2311 | 2.08 |
2018 (6) | 145.66 | 6.27 | 46.5 | 8.95 | 14.84 | -1.79 | 0 | 0 | 31.92 | 2.53 | 10.19 | -7.58 | 0.00 | 0 | 2264 | 14.17 |
2017 (5) | 137.07 | -3.15 | 42.68 | -12.29 | 15.11 | 3.49 | 0 | 0 | 31.14 | -9.44 | 11.02 | 6.86 | 0.00 | 0 | 1983 | 0.61 |
2016 (4) | 141.53 | -4.69 | 48.66 | 19.24 | 14.6 | 16.43 | 0 | 0 | 34.38 | 25.1 | 10.32 | 22.15 | 0.00 | 0 | 1971 | 32.46 |
2015 (3) | 148.49 | -8.92 | 40.81 | 26.62 | 12.54 | -13.04 | 0 | 0 | 27.48 | 39.02 | 8.45 | -4.52 | 0.00 | 0 | 1488 | 1.64 |
2014 (2) | 163.03 | -18.99 | 32.23 | -11.84 | 14.42 | -0.41 | 0 | 0 | 19.77 | 8.82 | 8.84 | 22.93 | 0.00 | 0 | 1464 | 0.0 |
2013 (1) | 201.25 | -21.73 | 36.56 | -22.15 | 14.48 | 6.78 | 0 | 0 | 18.17 | 0 | 7.20 | 0 | 0.00 | 0 | 1464 | 0.0 |